Cross Cancer Institute ( Site 0207)

Edmonton, Alberta T6G 1Z2

0 studies enrolling now · 2 studies all time

What they study most

Classical Hodgkin Lymphoma, Hodgkin's Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Studies at this site

• A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68) — Completed
• Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) — Completed